Subscribe

RSS Feed (xml)

Powered By

Skin Design: Kisi Karunia
Base Code: Free Blogger Skins

Powered by Blogger

Wednesday, 22 April 2026

Global FMD Alert 2026: New Serotypes, Vaccine Gaps, and Rising Outbreak Risks

 

Current Global Situation and Emerging Risks for Foot-and-Mouth Disease

GF-TADs Webinar, 20 April 2026

SUMMARY

 

The current global situation of foot-and-mouth disease (FMD) reflects an increasingly complex and dynamic landscape, driven by the emergence and spread of new viral serotypes that challenge existing control strategies. While serotype O continues to dominate globally and serotype C has not been detected since 2004, recent years have seen significant incursions of SAT1 and SAT2 into previously unaffected regions, including the Middle East, Europe, and parts of Asia. The spread of the SA2018 lineage of serotype O from Pool 2 into Pool 3 countries has further complicated the epidemiological picture, contributing to a substantial proportion of cases in countries such as India and triggering outbreaks across multiple regions. At the same time, repeated introductions of SAT1 and SAT2 viruses from East Africa into the Middle East suggest critical gaps in quarantine systems and animal movement controls. Of particular concern is the emergence of SAT1 topotype 3, which may be associated with vaccine escape or failures in biocontainment, and has already caused widespread outbreaks across Europe, the Middle East, and more recently China.

These evolving dynamics have also led to significant consequences for disease status in several regions. In Southern Africa, multiple countries have lost their FMD-free status due to outbreaks involving SAT1, SAT2, and SAT3 serotypes. The increasing detection of SAT1 topotype 3 in this region, including circulation of wild-type viruses, raises serious concerns about transmission between wildlife and domestic livestock, as well as the growing risk of transboundary spread. This situation highlights the fragile nature of disease-free status and underscores the importance of sustained vigilance, particularly in regions where wildlife reservoirs play a critical epidemiological role.

Efforts to control FMD are further complicated by challenges related to vaccine efficacy and matching. Current vaccine matching studies indicate that existing vaccines can provide reasonable protection against circulating SAT1 topotype 1 strains. However, the emergence of SAT1 topotype 3 presents a new and significant challenge due to its distinct genetic and antigenic characteristics, which may reduce the effectiveness of available vaccines. These developments emphasize the urgent need for continuous evaluation of vaccine performance, rapid updating of vaccine strains, and stronger global coordination to ensure vaccine availability and suitability in affected regions.

The introduction of new viral strains into previously unexposed, or naïve, populations significantly increases the risk of rapid disease spread and complicates control efforts. In such contexts, enhanced surveillance systems, timely vaccine matching, and strong cross-border collaboration become essential components of effective disease management. Without these measures, the potential for widespread outbreaks and substantial economic losses remains high.

A robust FMD risk monitoring and control framework is therefore critical to support timely and informed decision-making. This framework relies on the integration of multiple data sources, surveillance systems, and analytical tools to detect early warning signals and translate them into prioritized actions. The approach emphasizes strengthening and utilizing existing systems rather than creating parallel structures, ensuring that risk information is effectively communicated and operationalized. Semi-quantitative tools, such as those developed by EUFMD, enable the assessment of various risk pathways by analyzing factors such as connectivity between countries, disease prevalence, transmission efficiency, and the effectiveness of mitigation measures. These tools draw on diverse data sources, including FAO’s EMPRES-i, WOAH’s WAHIS, and global trade and livestock databases, providing a comprehensive basis for risk assessment.

Practical applications of these tools have demonstrated their value in identifying high-risk scenarios and guiding targeted interventions. For example, risk assessments have shown that informal livestock movements and shared grazing practices represent some of the most significant pathways for disease spread. Rapid assessments conducted for emerging strains, such as SAT1, have revealed moderate to high levels of impact and uncertainty, with several high-risk countries subsequently reporting outbreaks shortly after being identified. Seasonal and cultural factors, including periods of increased animal movement associated with religious festivals, further amplify these risks and must be incorporated into risk management strategies.

Translating risk signals into effective operational measures is a critical step in controlling FMD. This includes implementing targeted border controls, adapting surveillance strategies, and aligning vaccination programs with evolving risk profiles. Countries experiencing incursions of new serotypes must enhance the sensitivity of case definitions and strengthen frontline veterinary guidance to ensure early detection. Scaling up mitigation and monitoring efforts is particularly important in naïve populations, where the introduction of new strains can lead to rapid and extensive outbreaks. Looking ahead, the integration of emerging technologies, such as machine learning, offers promising opportunities to enhance risk prediction and surveillance capabilities, although these must be complemented by strong field-level intelligence and expertise.

Early detection and thorough outbreak investigation remain fundamental to minimizing the scale and impact of FMD epidemics. Prompt identification of suspected cases enables rapid implementation of control measures, reducing the likelihood of secondary spread and limiting production losses. This process depends heavily on effective passive surveillance systems, which in turn rely on the awareness and engagement of farmers and veterinarians. Immediate reporting of suspected cases triggers official investigations and laboratory confirmation, forming the basis for timely and coordinated responses.

However, detecting FMD is not always straightforward, particularly in species where clinical signs may be mild or atypical. While cattle and pigs often exhibit clear symptoms, small ruminants may show only subtle signs, allowing the disease to spread undetected. In high-risk areas, even minor signs such as lameness or small lesions in these species should be treated with suspicion and investigated promptly. Although detection in wildlife remains challenging, targeted surveillance and reports from hunters can provide valuable information in certain contexts.

Comprehensive outbreak investigations involve detailed epidemiological analysis, including establishing timelines, assessing lesion development, tracing animal movements, and conducting laboratory testing. Increasingly, full genome sequencing is being used to better understand virus evolution and transmission pathways, thereby informing more effective control strategies and vaccine selection. Regional coordination and data sharing play a crucial role in enhancing the overall understanding of outbreaks and improving response effectiveness.

Equally important is the role of communication and trust in ensuring the success of surveillance and control efforts. Clear and consistent communication with all stakeholders, particularly smallholder farmers, encourages timely reporting and compliance with control measures. Providing transparent information about the implications of reporting, as well as the consequences of failing to do so, helps build cooperation and strengthens the overall response system. Capacity building in veterinary services, including training in epidemiology and outbreak investigation, remains a key priority to improve detection and response capabilities, especially in challenging contexts such as small ruminant populations.

Transparency and timely sharing of risk information are foundational to effective global FMD control and the stability of international trade. Open and accurate reporting reduces uncertainty, supports science-based decision-making, and enables rapid deployment of control measures such as diagnostics and movement restrictions. It also fosters trust among trading partners and stakeholders, minimizing misinformation and speculation. International standards require countries to report animal disease events promptly and comprehensively, including relevant epidemiological details and control actions, and to provide follow-up reports until outbreaks are resolved.

Despite these obligations, challenges in timely reporting persist in some regions, often due to complex circumstances such as conflict or limited resources. Delays in reporting can undermine global surveillance efforts and hinder timely responses. To address this, international organizations increasingly rely on supplementary information sources, including media monitoring and intelligence gathering, to identify potential unreported events and engage with countries for clarification. Ultimately, transparency must be viewed as a shared responsibility, requiring commitment from all stakeholders to ensure effective disease control and rapid mobilization of support when needed.

Looking forward, the evolving epidemiology of FMD underscores the need for stronger cross-sector collaboration, adaptive risk management, and the integration of new technologies. Current evidence suggests that many recent outbreaks are driven not by environmental factors but by failures in quarantine systems and uncontrolled animal movements, particularly along established trade routes. Improving surveillance in naïve populations remains a priority, as diagnostic challenges such as serological cross-reactivity can complicate early detection, making clinical vigilance even more important.

Efforts are also underway to strengthen global coordination through initiatives such as the Global Partnership Program for Transboundary Animal Diseases, which aims to enhance country-driven prevention, early warning, and response capacities. Continued dialogue, knowledge sharing, and innovation will be essential to address emerging challenges, including vaccine security and genomic surveillance. In this context, sustained commitment from the global community is crucial to effectively manage FMD risks and protect both animal health and livelihoods worldwide.


#FMD 

#AnimalHealth 

#GlobalOutbreak 

#VeterinaryScience 

#DiseaseControl

No comments: